Phi news and features
|
20/12/2016 - Phi Pharma announces closing of CHF 3.7 million (US$3.6 million) series A financing
Read Article |
| ||
|
14/12/2016 - Phi Pharma appoints Dr Tom Shepherd as Chief Executive Officer and Dr Andreas Peer as Head of Chemistry.
Read Article |
| ||
|
12/10/2016 - Phi Pharma collaboration with HES-SO Valais-Wallis in Sion awarded a Swiss CTI Innovation grant to support the generation of proof of concept for a candidate peptide drug conjugate in an oncology indication.
Read article |
| ||